![]() The plan includes real-time, day to day observation and documentation of site work processes to ensure procedures are followed. Benchmark maintains an active Clinical Trial Quality Plan that defines proactive procedures to ensure that all trials are compliant with ICH and GCP guidelines, FDA regulations, sponsor requirements, protocol requirements and Benchmark policies. Our quality assurance program is guided by a former FDA investigator with extensive training experience and more than 30 years in the research industry at both site and industry levels. Our integrity is recognized through the utmost quality and safety protocols that Benchmark Research adheres to. In addition, Benchmark Research is a founding member within VaxCorps - a network of highly experienced, geographically diverse clinical research centers that have successfully conducted over 500 phase I-IV vaccine clinical trials, with extensive experience in seasonal and pandemic influenza as well as a vast array of other infectious and biodefense vaccine indications. We work in partnership with the private and public sectors at clinics located in California, Louisiana and Texas to ensure you get safe and effective medications and vaccines. ![]() We have developed a track record of safety and expertise, having conducted more than 1,000 trials with 40,000+ participants. Brian Bearie who has over 21 years of experience in the medical field.īenchmark Research was founded in 1997 by Mark Lacy, CEO and Scott Barrett, President. The Principal Investigator for this location will be Dr. ![]() The practice partnering with Benchmark in this inspiring venture has over 100,000 patient visits each year. 8, 2020 /PRNewswire-PRWeb/ - We are pleased to announce the opening of our 6th site and 1st site within Los Angeles, Benchmark SoCal! Located in the central area of 11 Urgent Cares in the San Bernardino district, Benchmark SoCal has quickly been recognized for its integrity since opening having been awarded 2 Coronavirus studies and two diagnostic studies. sites on the Pfizer and Moderna #COV19 vaccine trials.AUSTIN, Texas, Oct. Benchmark Research is teaming up with pharmaceutical companies to launch clinical research trials in Sacramento. Sponsors are taking notice and driving a lot of this shift.Īt the outset of COVID, CRIO’s system was leveraged by nearly a quarter of the U.S. Investors built these networks for three unique reasons (that aren’t going away).ġ) Centralized business development places studies at multiple sites with centralized contracting and budgeting.Ģ) Local recruiting x National Marketing makes it easier to fill studies.ģ) Standardized operations and systems mean a single electronic source template for sites with centralized and offshore #EDC entry and other activities. There are 5X as many site networks today as in 2015. Wiki Bio of Mark Lacy net worth is updated in 2023. Mark Lacy wiki ionformation include family relationships: spouse or partner (wife or husband) siblings childen/kids parents life. Mark Lacy body measurments, height, weight and age details. Orantes, Co-Chief Diversity Officer of hyperCORE & CEO at Alcanza Clinical Research Nicholas Focil, Chief Quality Management Officer at hyperCORE & CEO FOMAT Medical Research Nathan Morton, Chief Vaccine Officer at hyperCORE & Chief Commercial Officer at Alcanza Clinical Research #researchaccelerated #clinicalresearch #networking #supernetwork Complete Wiki Biography of Mark Lacy, which contains net worth and salary earnings in 2023. ROBERTO Aguirre, Chief Medical Officer at hyperCORE & VP/Global Medical Director at AGA Clinical Trials Carlos E. Samir Arora, Chief Corporate Development Officer of hyperCORE & CGO at Centricity Researchĭr. Jeff Kingsley, COO of hyperCORE & CEO at Centricity Research Jeffrey Smyth, CFO of hyperCORE & Executive Director at TrueBlue Clinical Researchĭr. ![]() Mark Lacy, Chairman of hyperCORE & CEO of Benchmark Research Karri Venn, CEO of hyperCORE & COO at Centricity Researchĭr. Say hello to our hyperCORE leadership at World Vaccine Congress: Find out what strategic partnerships within our super network can do to accelerate your #clinicaltrials site capabilities in both quality and #diversity. Our leadership team is headed to The World Vaccine Congress 2023 on April 3-6 in Washington, DC, and we look forward to seeing you there! Make sure to schedule a meeting with Michael Casey, Executive Director of hyperCORE, or reach out to our leadership team when you stop by Booth 501.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |